Funded Biomarker Testing
1 items
Reflex testing on newly diagnosed invasive gastroesophageal adenocarcinomas.
Funded Biomarker Disease Site: Esophagus, Stomach
Biomarker: MLH1, MSH2, MSH6, PMS2, HER2
Testing Method:Immunohistochemistry (IHC)
Testing Site: Hamilton Health Sciences, Health Sciences North, Kingston Health Sciences Centre, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, Unity Health - St. Michael's Hospital, University Health Network, William Osler Health System